Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

Despite the recent rally, biotechnology is still significantly underpriced relative to historical averages. However, profitability is far below the historical baseline.

Healthcare And Biotechnology Dashboard - Update.

SPDR S&P Biotech ETF

There's a catalyst on the horizon that could send biotech stocks soaring into the stratosphere.

You Can’t Afford to Miss This Buying Opportunity

The IBB Nasdaq Biotech ETF is up nearly 30% since October. Could the red-hot space be in danger of burning itself out?

Biotech is hot, but it might be about to burn out, says top technician

iShares U.S. Medical Devices ETF

Vanguard Health Care ETF

The major breakouts in several of the health care ETFs were a reason to buy in November and Tom Aspray takes a new look at their charts.

Healthcare Investors Take Note

Virtus LifeSci Biotech Clinical Trials ETF

Loncar Cancer Immunotherapy ETF

Global X Genomics & Biotechnology ETF

ALPS Medical Breakthroughs ETF

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Biotech ETFs Hit New Highs on Deal Activities

iShares Nasdaq Biotechnology ETF is benefitting from reduced regulatory risk in the middle term.

IBB Is Positioned For Outperformance

CME Group

CRISPR Therapeutics

NVIDIA

In 5 years, you be selling your gold and buying more companies leading the century of biology.

Trade of the 2020's: Sell Gold, Buy Biotech

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

Invesco Dynamic Biotechnology & Genome ETF

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

A Guide to Biotech ETF Investing

Biotech stocks had a fairly robust November, with the iShares NASDAQ Biotechnology Index advancing over 10% for the month.

Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates

This biotechnology ETF hit a new 52-week high. Are more gains in store for this ETF?

Biotechnology ETF (IBB) Hits New 52-Week High

Global Blood Therapeutics

Tesla

SPDR Gold Trust

Why Gold is Headed to Zero -- And What You Should Buy Instead

Novartis

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to drive the biotech market.

Why Biotech ETFs Surged in Monday's Trading Session

iShares U.S. Healthcare Providers ETF

Biotech stocks have outpaced the rest of the market over the past week, but Oppenheimer's Ari Wald sees better opportunity in managed care.

Biotech is busting out, but trader says this corner of health care is better bet

Biotechnology ETFs, including the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), have been rebounding for over a month, but investors remain apprehensive about the group.

Biotech ETF Rally Not Yet Luring Investors

Biotech stocks have joined the fourth quarter rally and could post strong gains in the coming months.

Biotech Stocks Awaken From Long Slumber

First Trust Industrials/Producer Durables AlphaDEX Fund

Janus Henderson Small Cap Growth Alpha ETF

First Trust Rising Dividend Achievers ETF

Invesco S&P 500 Enhanced Value ETF

SPDR S&P Semiconductor ETF

The latest rally has been broad based with many corners of the space generating above-market returns over a month.

Top-Ranked ETFs That Crushed the Market in a Month

iShares MSCI Emerging Markets ETF

iShares U.S. Regional Banks ETF

iShares Transportation Average ETF

KB Financial Group

Invesco KBW Bank ETF

SPDR S&P Regional Banking ETF

VanEck Vectors Oil Services ETF

Invesco WilderHill Clean Energy ETF

First Trust NASDAQ Clean Edge Green Energy Index Fund

Energy Select Sector SPDR Fund

Health Care Select Sector SPDR Fund

SPDR S&P Oil & Gas Exploration & Production ETF

SPDR S&P Transportation ETF

Morgan Stanley outlined four outcomes of the 2020 election and its strategies for investors on how to make the most of them.

Follow Morgan Stanley to Trade 2020 Election With ETFs

With the major averages at new all-time highs, Tom Aspray still likes the potential of three health care ETFs.  He explains why he likes these three and proposes a strategy for getting invested in these ETFs.

3 Ways To Invest $2000 in Healthcare

Biotechnology stocks have been outperforming over the past month, but ETF investors seem disinterested and are even trimming exposure to this sector.

The Unloved Biotechnology ETF Rally

The biotechnology sector is up over 8% in October, lead by large-cap companies Biogen, Amgen and Celgene.

Biotech stocks win October, rallying 8%

While the healthcare ETFs like the iShares Nasdaq Biotechnology ETF (IBB) are pulling back slightly this morning, mainly due to Amgen declining today, despite beating its earnings estimates and raising its full-year guidance, the overall healthcare sector is a top performer for October.

Healthcare ETFs Are Top Performers for October

These exchange-traded funds offer investors an easy way to potentially profit from growth in the healthcare sector.

5 Top Healthcare ETFs

Shares of Biogen Inc. rocketed higher on Tuesday, headed for their strongest performance in 20 years, after the biotechnology company surprised investors by stating that its Alzheimer’s treatment was prepared to start the regulatory approval process, as well as from third-quarter earnings that handily beat expectations.

Biotech ETF Rallies on Alzheimer Treatment News

The iShares Nasdaq Biotechnology ETF (IBB), the largest biotech-related ETF by assets, closed lower last Friday, but for the week, the fund gained 2%. That could be a sign downtrodden biotech ETFs are poised to bounce back.

It Could be to Time to Bank on Biotech ETFs

The healthcare sector, led by ETFs like the SPDR Health Care ETF (XLV), is helping to drive stocks higher on Tuesday, along with technology. XLV is up over 1.67%, as reported earnings from several major healthcare companies are driving stock prices up.

News for iShares Nasdaq Biotechnology ETF ETF (IBB)